作者：
Bell, Catherine C. [1]
;
Dankers, Anita C. A. [2]
;
Lauschke, Volker M. [3]
;
Sison-Young, Rowena [4]
;
Jenkins, Roz [5]
;
Rowe, Cliff [6]
;
Goldring, Chris E. [7]
;
Park, Kevin [8]
;
Regan, Sophie L. [9]
;
Walker, Tracy ;
Schofield, Chris ;
Baze, Audrey ;
Foster, Alison J. ;
Williams, Dominic P. ;
van de Ven, Amy W. M. ;
Jacobs, Frank ;
van Houdt, Jos ;
Lahteenmaki, Tuula ;
Snoeys, Jan ;
Juhila, Satu ;
Richert, Lysiane ;
Ingelman-Sundberg, Magnus
作者单位：
AstraZeneca, Safety & ADME Translat Sci, Drug Safety & Metab, IMED Biotech Unit, Cambridge, England
[1]
Karolinska Inst, Pharmacogenet Sect, Dept Physiol & Pharmacol, Stockholm, Sweden
[2]
AstraZeneca, Pathol Drug Safety & Metab, IMED Biotech Unit, Gothenburg, Sweden
[3]
Univ Liverpool, MRC Ctr Drug Safety Sci, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England
[4]
Orion Pharma, Vitro Biol, Espoo, Finland
[5]
GlaxoSmithKline Res & Dev Ltd, Invest Safety & Drug Metab, Ware, Herts, England
[6]
GSK, Med Res Ctr, Stevenage, Herts, England
[7]
Johnson & Johnson, Dept Pharmacokinet Dynam & Metab, Janssen Pharmaceut Co, Beerse, Belgium
[8]
KaLy Cell, Plobsheim, France
[9]
发布时间
2018-12-12
换一批
